
Reset all filters
01 6Ascent Innovative Medicines
02 2Aurobindo Pharma Limited
03 2Hetero Drugs
04 2Hikma Pharmaceuticals
05 9MSD Pharmaceuticals
06 2Merck & Co
Reset all filters
01 3Film Coated Tablet
02 14TABLET;ORAL
03 2Tablet
04 4Blank
Reset all filters
01 1Allowed
02 2Approved
03 6DISCN
04 8RX
05 6Blank
Reset all filters
01 6ERTUGLIFLOZIN
02 4SEGLUROMET
03 2STEGLATRO
04 2STEGLUJAN
05 3Steglatro
06 6Blank
Reset all filters
01 6India
02 2Sweden
03 1Switzerland
04 14USA
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 15MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Ertugliflozin; Sitagliptin Phosphate
Brand Name :
Dosage Form :
Dosage Strength : 2.5MG; 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Ertugliflozin; Sitagliptin Phosphate
Brand Name :
Dosage Form :
Dosage Strength : 2.5MG; 1G
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Ertugliflozin; Sitagliptin Phosphate
Brand Name :
Dosage Form :
Dosage Strength : 7.5MG; 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Ertugliflozin; Sitagliptin Phosphate
Brand Name :
Dosage Form :
Dosage Strength : 7.5MG; 1G
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ERTUGLIFLOZIN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2023-07-13
Application Number : 216947
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ERTUGLIFLOZIN
Dosage Form : TABLET;ORAL
Dosage Strength : 15MG
Packaging :
Approval Date : 2023-07-13
Application Number : 216947
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ERTUGLIFLOZIN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2024-09-17
Application Number : 217071
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ERTUGLIFLOZIN
Dosage Form : TABLET;ORAL
Dosage Strength : 15MG
Packaging :
Approval Date : 2024-09-17
Application Number : 217071
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ERTUGLIFLOZIN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2025-01-21
Application Number : 216842
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ERTUGLIFLOZIN
Dosage Form : TABLET;ORAL
Dosage Strength : 15MG
Packaging :
Approval Date : 2025-01-21
Application Number : 216842
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : STEGLATRO
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2017-12-19
Application Number : 209803
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : STEGLATRO
Dosage Form : TABLET;ORAL
Dosage Strength : 15MG
Packaging :
Approval Date : 2017-12-19
Application Number : 209803
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
ERTUGLIFLOZIN; SITAGLIPTIN PHOSPHATE
Brand Name : STEGLUJAN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG;EQ 100MG BASE
Packaging :
Approval Date : 2017-12-19
Application Number : 209805
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
ERTUGLIFLOZIN; SITAGLIPTIN PHOSPHATE
Brand Name : STEGLUJAN
Dosage Form : TABLET;ORAL
Dosage Strength : 15MG;EQ 100MG BASE
Packaging :
Approval Date : 2017-12-19
Application Number : 209805
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE
Brand Name : SEGLUROMET
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;500MG
Packaging :
Approval Date : 2017-12-19
Application Number : 209806
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE
Brand Name : SEGLUROMET
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;1GM
Packaging :
Approval Date : 2017-12-19
Application Number : 209806
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE
Brand Name : SEGLUROMET
Dosage Form : TABLET;ORAL
Dosage Strength : 7.5MG;500MG
Packaging :
Approval Date : 2017-12-19
Application Number : 209806
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE
Brand Name : SEGLUROMET
Dosage Form : TABLET;ORAL
Dosage Strength : 7.5MG;1GM
Packaging :
Approval Date : 2017-12-19
Application Number : 209806
Regulatory Info : RX
Registration Country : USA